Fu Y S, Reagan J W, Fu A S, Janiga K E
Cancer. 1982 Jun 15;49(12):2571-7. doi: 10.1002/1097-0142(19820615)49:12<2571::aid-cncr2820491226>3.0.co;2-9.
The prognosis of the glandular neoplasms of the uterine cervix is related to the clinical stage and, to a lesser extent, to the histologic type, growth pattern, and degree of differentiation of the neoplasms. To determine further the prognostic significance of the stem cell ploidy levels as determined by nuclear DNA quantitation, the authors separated the tumors into low ploidy (less than 3N) and high ploidy (greater than 3N) groups. Of the clinical Stage I and II neoplasms, low ploidy tumors had a better prognosis than high ploidy tumors of comparable stage. Low ploidy tumors had a better prognosis than high ploidy tumors irrespective of the degree of differentiation. Mixed carcinomas had a poorer prognosis than pure adenocarcinomas of comparable clinical stage. This might be explained by the greater proportion of high ploidy stem cells in mixed carcinomas than in pure adenocarcinomas. Although advanced clinical Stage III and IV neoplasms had a poor outlook regardless of the DNA ploidy level, there was a proportional increase of high ploidy tumors with increasing clinical stage. These findings suggest that cervical granular neoplasms having high ploidy stem cell lines are biologically more aggressive than those with low ploidy stem cell lines.
子宫颈腺性肿瘤的预后与临床分期有关,在较小程度上还与肿瘤的组织学类型、生长方式及分化程度有关。为了进一步确定通过核DNA定量所测定的干细胞倍体水平的预后意义,作者将肿瘤分为低倍体(小于3N)和高倍体(大于3N)两组。在临床I期和II期肿瘤中,低倍体肿瘤的预后比相同分期的高倍体肿瘤好。无论分化程度如何,低倍体肿瘤的预后都比高倍体肿瘤好。混合性癌的预后比相同临床分期的纯腺癌差。这可能是因为混合性癌中高倍体干细胞的比例高于纯腺癌。尽管临床III期和IV期晚期肿瘤无论DNA倍体水平如何预后都较差,但随着临床分期的增加,高倍体肿瘤的比例呈相应增加。这些发现表明,具有高倍体干细胞系的宫颈颗粒性肿瘤在生物学上比具有低倍体干细胞系的肿瘤更具侵袭性。